Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Vibe Growth Corp C.VIBE

Alternate Symbol(s):  VIBEF

Vibe Growth Corporation is a Canada-based vertically integrated cannabis retailer. The Company is engaged in evaluating, acquiring, and developing cannabis cultivation, distribution and manufacturing assets and retail cannabis dispensaries, in the United States. The Company has retail dispensaries, cannabis greenhouse cultivation, premium indoor cultivation, commercial cannabis distribution, brand sales and marketing, e-commerce platform, home delivery, and Hype Cannabis Co. marijuana and Vibe CBD products. In addition, it is also focused on new dispensaries delivering a retail experience under Vibe by California branded stores. It is focused on the point-of-sale process at its dispensary locations and product delivery methods. The Company operates approximately five dispensaries, one distribution center and one cultivation operation in the State of California, plus one dispensary in Portland, Oregon. The Company operates retail and ecommerce under its Vibe by California brand.


CSE:VIBE - Post by User

Post by Duster340on Dec 23, 2022 12:27pm
163 Views
Post# 35189731

A new low of 41 cents

A new low of 41 centsinvestors geting nervous, or just fed up. always have to wait to the last minute or longer for promised news update.

Upcoming Milestones

The following summarizes the Company’s estimated timeline for its key upcoming milestones:

  • Select lead candidate for inflammatory bowel disease – calendar Q4 2022
<< Previous
Bullboard Posts
Next >>